Differences in De Novo Donor-Specific Anti-HLA Antibodies Between Living-Donor Lobar and Cadaveric Lung Transplantation

被引：0
作者：
Gochi, F. [1 ]
Chen-Yoshikawa, T. F. [1 ]
Kondo, T. [1 ]
Ohsumi, A. [1 ]
Ohata, K. [1 ]
Takahagi, A. [1 ]
Saito, M. [1 ]
Okabe, R. [1 ]
Yamagishi, H. [1 ]
Hamaji, M. [1 ]
Hijiya, K. [1 ]
Motoyama, H. [1 ]
Aoyama, A. [1 ]
Date, H. [1 ]
机构：
[1] Kyoto Univ Hosp, Grad Sch Med, Dept Thorac Surg, Kyoto, Japan
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2017年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1238
引用
收藏
页码：S403 / S404
页数：2
相关论文
共 50 条
  • [31] Relevance of donor-specific anti-HLA antibodies following renal transplantation.
    Supon, P
    Constantino, D
    Hao, P
    Cagle, LR
    Hahn, A
    Conti, DJ
    Freed, BM
    TRANSPLANTATION, 2000, 69 (08) : S185 - S185
  • [32] Comparison of living-donor lobar lung transplantation and cadaveric lung transplantation for pulmonary hypertension
    Kayawake, Hidenao
    Tanaka, Satona
    Yamada, Yoshito
    Baba, Shiro
    Kinoshita, Hideyuki
    Yamazaki, Kazuhiro
    Ikeda, Tadashi
    Minatoya, Kenji
    Yutaka, Yojiro
    Hamaji, Masatsugu
    Ohsumi, Akihiro
    Nakajima, Daisuke
    Date, Hiroshi
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2023, 63 (04)
  • [33] Donor-Specific Anti-HLA Antibodies in Allogeneic Hematopoietic Stem Cell Transplantation
    Morin-Zorman, Sarah
    Loiseau, Pascale
    Taupin, Jean-Luc
    Caillat-Zucman, Sophie
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [34] De Novo Donor-Specific Anti-HLA Antibodies Are a Risk Factor for the Development of Biliary Strictures After DBD Liver Transplantation
    Foley, D.
    Ellis, T.
    D'Alessandro, A.
    Powell, A.
    Leverson, G.
    Musat, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 177 - 177
  • [35] High incidence of humoral rejection in recipients with de novo donor-specific Anti-HLA antibodies after living-related kidney transplantation.
    Li, Xiaobei
    Ishida, Hideki
    Shimizu, Tomokazu
    Shirakawa, Hiroki
    Setoguchi, Kiyoshi
    Toki, Daisuke
    Iida, Shouichi
    Nishida, Hayato
    Tanabe, Kazunari
    AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 : 287 - 288
  • [36] De Novo Donor-Specific Anti-HLA Antibodies Are a Risk Factor for the Development of Biliary Strictures After DBD Liver Transplantation
    Foley, D.
    Ellis, T.
    D'Alessandro, A.
    Powell, A.
    Leverson, G.
    Musat, A.
    TRANSPLANTATION, 2014, 98 : 177 - 177
  • [37] Impact of Low Dose Donor Specific Anti-HLA Antibodies between Living Donor versus Deceased Donor Kidney Transplantation
    Kim, S.
    Lee, S.
    Ko, E.
    Ban, T.
    Min, J.
    Yoon, H.
    Yang, C.
    Chung, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 846 - 846
  • [38] Removal of donor-specific anti-HLA class 1 antibodies using plasmapheresis to enable successful living donor renal transplantation
    不详
    INTERNATIONAL JOURNAL OF IMMUNOGENETICS, 2005, 32 (04) : 264 - 264
  • [39] Non-Complement-Binding De Novo Donor-Specific Anti-HLA Antibodies and Kidney Allograft Survival
    Guidicelli, Gwendaline
    Guerville, Florent
    Lepreux, Sebastien
    Wiebe, Chris
    Thaunat, Olivier
    Dubois, Valerie
    Visentin, Jonathan
    Bachelet, Thomas
    Morelon, Emmanuel
    Nickerson, Peter
    Merville, Pierre
    Taupin, Jean-Luc
    Couzi, Lionel
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2016, 27 (02): : 615 - 625
  • [40] Luminex Solid-Phase Crossmatch for De Novo Donor-Specific Antibodies in Living-Donor Related Transplants
    Mehrotra, Sonia
    Sharma, Raj Kumar
    Mayya, Mahabaleshwar
    Gupta, Amit
    Prasad, Narayan
    Kaul, Anupma
    Bhadauria, Dharmendra Singh
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2017, 15 (04) : 394 - 399
12345